230 related articles for article (PubMed ID: 15322944)
41. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
[TBL] [Abstract][Full Text] [Related]
42. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
[TBL] [Abstract][Full Text] [Related]
43. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association.
Follansbee WP; Zerbe TR; Medsger TA
Am Heart J; 1993 Jan; 125(1):194-203. PubMed ID: 8417518
[TBL] [Abstract][Full Text] [Related]
44. [Dropped head sign and tongue atrophy in systemic sclerosis-associated myopathy: a case report].
Yoshinaga T; Miyazaki D; Fukushima K; Shimojima Y; Matsuda M; Ikeda S
Rinsho Shinkeigaku; 2010 Oct; 50(10):732-5. PubMed ID: 21061555
[TBL] [Abstract][Full Text] [Related]
45. Prediction of pulmonary complications and long-term survival in systemic sclerosis.
Nihtyanova SI; Schreiber BE; Ong VH; Rosenberg D; Moinzadeh P; Coghlan JG; Wells AU; Denton CP
Arthritis Rheumatol; 2014 Jun; 66(6):1625-35. PubMed ID: 24591477
[TBL] [Abstract][Full Text] [Related]
46. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
[TBL] [Abstract][Full Text] [Related]
47. Scleromyxedema with myopathy and hyperthyroidism.
Van Linthoudt D; Schumacher HR; Algeo S; Freundlich B; Schotland DL; Wood MG
J Rheumatol; 1996 Jul; 23(7):1299-301. PubMed ID: 8823713
[TBL] [Abstract][Full Text] [Related]
48. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.
Savarino E; Bazzica M; Zentilin P; Pohl D; Parodi A; Cittadini G; Negrini S; Indiveri F; Tutuian R; Savarino V; Ghio M
Am J Respir Crit Care Med; 2009 Mar; 179(5):408-13. PubMed ID: 19096004
[TBL] [Abstract][Full Text] [Related]
49. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
[TBL] [Abstract][Full Text] [Related]
50. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA
J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118
[TBL] [Abstract][Full Text] [Related]
51. Serum levels of monocyte chemotactic protein-3/CCL7 are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis.
Yanaba K; Komura K; Kodera M; Matsushita T; Hasegawa M; Takehara K; Sato S
Ann Rheum Dis; 2006 Jan; 65(1):124-6. PubMed ID: 16344498
[TBL] [Abstract][Full Text] [Related]
52. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: elevated MCP-1 is predominantly associated with fibrotic manifestations.
Yalçinkaya Y; Çinar S; Artim-Esen B; Kamali S; Öcal L; Deniz G; Inanç M
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):110-114. PubMed ID: 27749243
[TBL] [Abstract][Full Text] [Related]
53. Myofibroblast induction and microvascular alteration in scleroderma lung fibrosis.
Beon M; Harley RA; Wessels A; Silver RM; Ludwicka-Bradley A
Clin Exp Rheumatol; 2004; 22(6):733-42. PubMed ID: 15638048
[TBL] [Abstract][Full Text] [Related]
54. Systemic sclerosis-associated Sjögren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients.
Avouac J; Sordet C; Depinay C; Ardizonne M; Vacher-Lavenu MC; Sibilia J; Kahan A; Allanore Y
Arthritis Rheum; 2006 Jul; 54(7):2243-9. PubMed ID: 16802363
[TBL] [Abstract][Full Text] [Related]
55. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
[TBL] [Abstract][Full Text] [Related]
56. Clinical features of 405 Japanese patients with systemic sclerosis.
Hashimoto A; Endo H; Kondo H; Hirohata S
Mod Rheumatol; 2012 Apr; 22(2):272-9. PubMed ID: 21874591
[TBL] [Abstract][Full Text] [Related]
57. Elevated serum concentrations of polymorphonuclear neutrophilic leukocyte elastase in systemic sclerosis: association with pulmonary fibrosis.
Hara T; Ogawa F; Yanaba K; Iwata Y; Muroi E; Komura K; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Rheumatol; 2009 Jan; 36(1):99-105. PubMed ID: 19208531
[TBL] [Abstract][Full Text] [Related]
58. Relationship between cutaneous and pulmonary involvement in systemic sclerosis.
Morelli S; Barbieri C; Sgreccia A; Ferrante L; Pittoni V; Conti F; Gualdi G; Polettini E; Carlesimo OA; Calvieri S
J Rheumatol; 1997 Jan; 24(1):81-5. PubMed ID: 9002015
[TBL] [Abstract][Full Text] [Related]
59. Increased pigmentation in scleroderma.
Pope JE; Shum DT; Gottschalk R; Stevens A; McManus R
J Rheumatol; 1996 Nov; 23(11):1912-6. PubMed ID: 8923365
[TBL] [Abstract][Full Text] [Related]
60. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]